David A. Putnam

This paper develops programmable protein degraders (uAbs) that selectively knock down pathogenic β-catenin in vitro and in vivo, reducing tumor cell survival and proliferation.

This study engineers outer membrane vesicles displaying dengue EDIII antigens to elicit strong, serotype-specific immune responses and neutralizing antibodies against all four dengue serotypes.

This paper introduces AddVax, a method to decorate bacterial outer membrane vesicles with biotinylated antigens to create vaccines, showing strong immune responses in mice.